Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 826

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 826
---
 was received on December 28, 2021, and the Company issued shares and warrants in accordance with the Placement Agreement. As of December 31, warrants totaling 70,356 had expired. I.On December 12, 2022, the shareholders’ meeting approved the increase of the Company’s authorized share capital by 50,000,000shares, no par value, and the capital increase, respectively, so that after the capital increase, the authorized share capital of the Company was USD $2.9 million, divided into 100,000,000 ordinary shares. On December 12, 2022, the Company published a shelf offering by way of rights. Under the shelf offering, shares were offered by way of rights to the Company’s shareholders, in such a way that each shareholder who held 100 Shares would be entitled to purchase 1 rights unit. 1 rights unit consisted of 32 Shares, and the total price of each rights unit was USD $10. The total number of rights units offered was up to 14,623,392 rights units. Until December 31, 2022, the Company received notices for 47,574 rights (in exchange for which 1,522,335shares were issued as of the reporting date) for a total of USD $475 thousand. By the end of the financing round on January 9, 2023, the Company received notices for 390,220 rights to purchase 7,507,052 Shares of the Company. The gross immediate consideration received by the Company for the rights issued according to the shelf offering totaled USD $2,204 thousand (the issuance expenses totaled USD $52 thousand). On January 1, 2023, 2,175,800 Series 6 warrants expired. J.During the year 2023, the shareholders’ meeting approved the increase of the Company’s authorized share capital by 50,000,000 Shares, and the capital increase, respectively, so that the authorized share capital of the Company after the capital increase would be USD $4.4 million, divided into 150,000,000 ordinary shares. K.On March 31, 2024, the Company executed a reverse share split at a ratio of 1:10, whereby every ten Shares were consolidated into one ordinary share of NIS 1 par value. The reverse split was also applied to all outstanding convertible securities as of the date of the split. Annex G-36

KADIMASTEM LTD.
NOTES TO FIN